BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 24405414)

  • 1. Peptide nucleic acids: a review on recent patents and technology transfer.
    Gambari R
    Expert Opin Ther Pat; 2014 Mar; 24(3):267-94. PubMed ID: 24405414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peptide-nucleic acids (PNAs): a tool for the development of gene expression modifiers.
    Gambari R
    Curr Pharm Des; 2001 Nov; 7(17):1839-62. PubMed ID: 11562312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological activity and delivery of peptide nucleic acids (PNA)-DNA chimeras for transcription factor decoy (TFD) pharmacotherapy.
    Gambari R
    Curr Med Chem; 2004 May; 11(10):1253-63. PubMed ID: 15134518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular interactions with nuclear factor kappaB (NF-kappaB) transcription factors of a PNA-DNA chimera mimicking NF-kappaB binding sites.
    Romanelli A; Pedone C; Saviano M; Bianchi N; Borgatti M; Mischiati C; Gambari R
    Eur J Biochem; 2001 Dec; 268(23):6066-75. PubMed ID: 11733000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcription factor decoy molecules based on a peptide nucleic acid (PNA)-DNA chimera mimicking Sp1 binding sites.
    Borgatti M; Lampronti I; Romanelli A; Pedone C; Saviano M; Bianchi N; Mischiati C; Gambari R
    J Biol Chem; 2003 Feb; 278(9):7500-9. PubMed ID: 12446679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peptide nucleic acid (PNA): its medical and biotechnical applications and promise for the future.
    Ray A; Nordén B
    FASEB J; 2000 Jun; 14(9):1041-60. PubMed ID: 10834926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peptide nucleic acids with a structurally biased backbone. Updated review and emerging challenges.
    Corradini R; Sforza S; Tedeschi T; Totsingan F; Manicardi A; Marchelli R
    Curr Top Med Chem; 2011; 11(12):1535-54. PubMed ID: 21510833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defining the peptide nucleic acids (PNA) length requirement for PNA binding-induced transcription and gene expression.
    Wang G; Jing K; Balczon R; Xu X
    J Mol Biol; 2001 Nov; 313(5):933-40. PubMed ID: 11700050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Computational procedures to explain the different biological activity of DNA/DNA, DNA/PNA and PNA/PNA hybrid molecules mimicking NF-kappaB binding sites.
    Saviano M; Romanelli A; Bucci E; Pedone C; Mischiati C; Bianchi N; Feriotto G; Borgatti M; Gambari R
    J Biomol Struct Dyn; 2000 Dec; 18(3):353-62. PubMed ID: 11149512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delivery of Peptide Nucleic Acids Using an Argininocalix[4]arene as Vector.
    Finotti A; Gasparello J; Casnati A; Corradini R; Gambari R; Sansone F
    Methods Mol Biol; 2021; 2211():123-143. PubMed ID: 33336275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The peptide nucleic acids (PNAs): introduction to a new class of probes for chromosomal investigation.
    Pellestor F; Paulasova P
    Chromosoma; 2004 Jun; 112(8):375-80. PubMed ID: 15156326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liposomes as carriers for DNA-PNA hybrids.
    Nastruzzi C; Cortesi R; Esposito E; Gambari R; Borgatti M; Bianchi N; Feriotto G; Mischiati C
    J Control Release; 2000 Aug; 68(2):237-49. PubMed ID: 10925132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The peptide nucleic acids (PNAs): "high-tech" probes for genetic and molecular cytogenetic investigations].
    Pellestor F; Paulasova P; Macek M; Hamamah S
    Med Sci (Paris); 2005; 21(8-9):753-8. PubMed ID: 16115462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unlocking the potential of chemically modified peptide nucleic acids for RNA-based therapeutics.
    Pradeep SP; Malik S; Slack FJ; Bahal R
    RNA; 2023 Apr; 29(4):434-445. PubMed ID: 36653113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular properties and medical applications of peptide nucleic acids.
    Malcher J; Wesoły J; Bluyssen HA
    Mini Rev Med Chem; 2014 May; 14(5):401-10. PubMed ID: 24766383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extending recognition by peptide nucleic acids (PNAs): binding to duplex DNA and inhibition of transcription by tail-clamp PNA-peptide conjugates.
    Kaihatsu K; Shah RH; Zhao X; Corey DR
    Biochemistry; 2003 Dec; 42(47):13996-4003. PubMed ID: 14636068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peptide nucleic acid (PNA) binding-mediated gene regulation.
    Wang G; Xu XS
    Cell Res; 2004 Apr; 14(2):111-6. PubMed ID: 15115611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Peptide Nucleic Acids (PNA)--the explorer of gene mystery].
    Fei YN; Zhang FX
    Yi Chuan; 2006 May; 28(5):623-30. PubMed ID: 16735246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peptide nucleic acids: versatile tools for gene therapy strategies.
    Dean DA
    Adv Drug Deliv Rev; 2000 Nov; 44(2-3):81-95. PubMed ID: 11072107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evolution of peptide nucleic acid with modifications of its backbone and application in biotechnology.
    Das A; Pradhan B
    Chem Biol Drug Des; 2021 Apr; 97(4):865-892. PubMed ID: 33314595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.